Last year, the FDA put into place a 4-year window that allows e-cigarette manufacturers to continue production without any scrutiny from the government watchdog agency.
The reprieve will allow E-cigarette manufacturers to continue to produce their approved products without the oversite requested by a number of advocacy groups and health organizations.
The health effects and safety concerns revolving around e-cigarettes are in contention; the industry continues to claim that e-cigarettes are a healthy alternative to traditional smoking products, while some health experts believe that e-cigarettes pose the same risks, if not more of a risk to users.
Now that e-cigarette products have been “fast-tracked” through the FDA’s pre-market process, these advocacy groups and health organizations are mounting up to file suit against the FDA on grounds that the FDA unjustifiably delayed safety and health reviews for e-cigarette products.
